Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest Pain

Trial Profile

Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest Pain

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 21 Jun 2017

At a glance

  • Drugs Dronabinol (Primary)
  • Indications Chest pain
  • Focus Therapeutic Use
  • Acronyms ICAMP
  • Most Recent Events

    • 14 Jun 2017 Status changed from not yet recruiting to recruiting.
    • 22 Apr 2016 Planned initiation date changed from 1 Oct 2015 to 1 Jul 2016.
    • 08 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top